Comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 vs Abdominal Cystic Lymphangioma C2930929
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetoplacental Androgens Excess and Abdominal Cystic Lymphangioma for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
A condition where the placenta and fetus together produce excess androgens, affecting an XX embryo's development. It is present at birth. Multidisciplinary care helps manage physical and hormonal aspects.
Abdominal Cystic Lymphangioma C2930929
A non-cancerous fluid-filled growth developing from lymphatic vessels in the abdomen. Usually found in children. Treatment may involve surgical removal or other interventions.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Variable
Abdominal Cystic Lymphangioma C2930929
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
severe
Abdominal Cystic Lymphangioma C2930929
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
Chronic
Abdominal Cystic Lymphangioma C2930929
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
No
Abdominal Cystic Lymphangioma C2930929
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
reproductive
Abdominal Cystic Lymphangioma C2930929
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
endocrine
Abdominal Cystic Lymphangioma C2930929
rare-disease
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetoplacental-androgens-excess-C5679876 and abdominal-cystic-lymphangioma-C2930929 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | Abdominal Cystic Lymphangioma C2930929 | Discriminating power |
|---|---|---|---|
| Genital development | May affect development of an XX embryo and be evident at birth; features vary. | Genital development is not the defining feature in the supplied description. | High |
| Abdominal swelling or mass | An abdominal cystic mass is not described as its characteristic finding. | A noncancerous fluid-filled growth arising from abdominal lymphatic vessels. | High |
| Hormonal context | Associated with fetoplacental androgen excess; endocrine confirmation is not specified here. | Not described as an androgen or sex-development disorder. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 when
Atypical genital findings in a newborn with suspected XX karyotype
The source links excess androgens to altered XX development present at birth.
Moderate
Concern centers on hormones rather than an abdominal mass
The described mechanism is endocrine and developmental, not lymphatic.
Moderate
Planning coordinated congenital endocrine and surgical care
Multidisciplinary care is described for physical and hormonal aspects.
Moderate
Choose Abdominal Cystic Lymphangioma C2930929 when
A child has a suspected fluid-filled abdominal lesion
The source describes a benign abdominal lymphatic growth, usually found in children.
Moderate
Imaging suggests a cystic lymphatic malformation
That pattern fits the right concept better than a sex-development disorder.
Moderate
Management discussion involves removal or another local intervention
The source mentions surgical removal or other interventions.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876 | Abdominal Cystic Lymphangioma C2930929 | Interpretation |
|---|---|---|---|
| Karyotype or genetic sex evaluation | XX context is central, but testing details are not supplied. | Not described as necessary to define the lesion. | An abnormal or unexpected result needs specialist interpretation and is not itself a complete diagnosis. |
| Androgen or endocrine assessment | May be relevant because excess androgens are implicated; no cutoff is established here. | No characteristic endocrine abnormality is supplied. | Do not infer a diagnosis or threshold from this comparison alone. |
| Abdominal imaging | Not a defining test in the supplied description. | May show a cystic abdominal lesion, but imaging alone may not prove its nature. | Pathology or specialist review may be needed; exact criteria are not provided. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetoplacental Androgens Excess C5679876
- Outcome
- A chronic congenital condition whose individual outcome is not quantified here.
- Factors
- Supplied severity is severe; hormonal and physical management may influence care needs.
Abdominal Cystic Lymphangioma C2930929
- Outcome
- Often managed as a moderate benign lesion, but individual outcome is not established.
- Factors
- Size, symptoms, and response to removal or other intervention may matter.
Time frame: Both may require follow-up; no reliable timeline is supplied.
Prognosis should be individualized; no mortality or prevalence figures are established.
Complications comparison
| Complication | Presentation |
|---|---|
| Anatomic effects | Physical genital or reproductive effects may require specialist management. The growth may cause local abdominal effects, although specifics are not established. Neither complication profile is fully defined by the source. |
| Hormonal imbalance | Hormonal aspects are explicitly part of care. No hormonal complication is described. Avoid assuming shared endocrine complications. |
| Treatment-related problems | Long-term multidisciplinary follow-up may be needed; procedures are not specified. Removal or another intervention may be considered; recurrence risk is not quantified. No doses, operative method, or outcome rates are established here. |
Patient education highlights
- HighDifferent conditions
One concerns sex development from androgen exposure; the other is a benign abdominal lymphatic growth.
- HighSpecialist confirmation
Names and codes do not establish the diagnosis. A clinician must interpret examinations and tests.
- MediumCare planning
The left may need endocrine and psychosocial support; the right may need imaging and procedural discussion.